Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.68% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
IMCR · Jun 30, 2026
Immunocore Holdings plc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001671927-26-000022General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.74% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
18.34% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
6.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
99.06% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-2.58% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
63.79% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
8.11% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 1.67%
- Current
- 0.68%
- Delta
- -0.99%
- Previous
- -12.91%
- Current
- 13.74%
- Delta
- 26.65%
- Previous
- 13.63%
- Current
- 18.34%
- Delta
- 4.71%
- Previous
- 7.74%
- Current
- 6.72%
- Delta
- -1.02%
- Previous
- 99.59%
- Current
- 99.06%
- Delta
- -0.53%
- Previous
- 6.82%
- Current
- -2.58%
- Delta
- -9.41%
- Previous
- 57.29%
- Current
- 63.79%
- Delta
- 6.50%
- Previous
- 5.91%
- Current
- 8.11%
- Delta
- 2.20%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Derived From · IMCR Company Quality Vector →Has State · Immunocore Holdings plc →Transitioned To · IMCR INVENTORY_PRESSURE_DECREASED →Transitioned To · IMCR PROFITABILITY_DECREASED →Transitioned To · IMCR R_AND_D_INTENSITY_INCREASED →Transitioned To · IMCR SBC_INTENSITY_INCREASED →Transitioned To · IMCR Fundamental State →Transitioned To · IMCR CAPEX_INTENSITY_DECREASED →Transitioned To · IMCR CASH_GENERATION_INCREASED →Transitioned To · IMCR GROWTH_INCREASED →Transitioned To · IMCR MARGIN_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.